- Home
- ME vs HBIO Comparison
ME vs HBIO Comparison
Compare ME & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ME
- HBIO
- Stock Information
- Founded
- ME 2006
- HBIO 1901
- Country
- ME United States
- HBIO United States
- Employees
- ME N/A
- HBIO N/A
- Industry
- ME Precision Instruments
- HBIO Biotechnology: Laboratory Analytical Instruments
- Sector
- ME Health Care
- HBIO Industrials
- Exchange
- ME Nasdaq
- HBIO Nasdaq
- Market Cap
- ME 113.9M
- HBIO 106.4M
- IPO Year
- ME N/A
- HBIO 2000
- Fundamental
- Price
- ME $3.11
- HBIO $2.27
- Analyst Decision
- ME Hold
- HBIO
- Analyst Count
- ME 1
- HBIO 0
- Target Price
- ME $9.40
- HBIO N/A
- AVG Volume (30 Days)
- ME 453.1K
- HBIO 175.9K
- Earning Date
- ME 11-12-2024
- HBIO 11-07-2024
- Dividend Yield
- ME N/A
- HBIO N/A
- EPS Growth
- ME N/A
- HBIO N/A
- EPS
- ME N/A
- HBIO N/A
- Revenue
- ME $193,260,000.00
- HBIO $97,732,000.00
- Revenue This Year
- ME $21.93
- HBIO N/A
- Revenue Next Year
- ME $17.31
- HBIO N/A
- P/E Ratio
- ME N/A
- HBIO N/A
- Revenue Growth
- ME N/A
- HBIO N/A
- 52 Week Low
- ME $2.66
- HBIO $1.99
- 52 Week High
- ME $20.40
- HBIO $5.56
- Technical
- Relative Strength Index (RSI)
- ME 30.62
- HBIO 47.44
- Support Level
- ME $2.66
- HBIO $1.99
- Resistance Level
- ME $3.58
- HBIO $2.61
- Average True Range (ATR)
- ME 0.45
- HBIO 0.17
- MACD
- ME -0.08
- HBIO -0.01
- Stochastic Oscillator
- ME 16.90
- HBIO 33.73
About ME 23andMe Holding Co.
23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.